NA
NA2.F Natural Alternatives International Inc
- Market cap
- EUR 4.76M
- P/E
- -
- P/B
- 0.11x
- ROE
- -41.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is NA2.F undervalued?
Graham numberThe Graham number of Natural Alternatives International Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Natural Alternatives International Inc fundamental analysis
No fundamental analysis for Natural Alternatives International Inc yet.
Natural Alternatives International Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Natural Alternatives International Inc
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. The company operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It a…
Full company profileNatural Alternatives International Inc financial statements
Natural Alternatives International Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 122M | 132M | 138M | 119M | 179M | 171M | 154M | 114M | 130M | 143M |
| Gross Profit | 26.2M | 26.3M | 23.6M | 18.9M | 30.4M | 30.5M | 18.2M | 6.87M | 9.29M | 9.00M |
| Operating Income | 9.70M | 9.53M | 5.96M | -1.51M | 13.7M | 13.7M | 4.71M | -8.53M | -7.26M | -8.30M |
| EBITDA | 12.5M | 13.5M | 11.4M | 2.29M | 16.6M | 17.9M | 8.26M | -4.46M | -5.27M | -14.4M |
| Net Income | 7.24M | 5.05M | 6.54M | -1.65M | 10.8M | 10.7M | 2.52M | -7.22M | -13.6M | -20.7M |
| EPS | 1.04 | 0.67 | 0.91 | -0.24 | 1.67 | 1.75 | 0.42 | -1.16 | -2.20 | -3.30 |
| Balance Sheet | ||||||||||
| Total Assets | 72.6M | 85.2M | 93.5M | 120M | 120M | 146M | 134M | 162M | 152M | 126M |
| Total Liabilities | 11.5M | 17.0M | 17.4M | 48.8M | 40.2M | 57.5M | 45.4M | 79.7M | 83.5M | 76.5M |
| Shareholders' Equity | 61.1M | 68.2M | 76.1M | 71.4M | 80.1M | 88.5M | 88.8M | 82.6M | 68.4M | 50.0M |
| Cash & Short-term Investments | 27.8M | 23.6M | 25.0M | 30.5M | 32.1M | 21.8M | 13.6M | 12.0M | 12.3M | 7.39M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 14.1M | 1.83M | 6.56M | 3.69M | 20.8M | 11.9M | 7.02M | -1.50M | 5.93M | -8.92M |
| Capital Expenditure | 5.35M | 4.08M | 5.33M | 4.54M | 5.11M | 26.5M | 13.5M | 3.02M | 3.61M | 3.70M |
| Free Cash Flow | 8.78M | -2.25M | 1.24M | -850K | 15.7M | -14.6M | -6.51M | -4.51M | 2.32M | -12.6M |
| Ratios | ||||||||||
| ROE | 11.8% | 7.4% | 8.6% | -2.3% | 13.4% | 12.1% | 2.8% | -8.7% | -19.8% | -41.4% |
| ROA | 10.0% | 5.9% | 7.0% | -1.4% | 9.0% | 7.3% | 1.9% | -4.4% | -8.9% | -16.4% |
| Net Profit Margin | 5.9% | 3.8% | 4.7% | -1.4% | 6.0% | 6.3% | 1.6% | -6.3% | -10.5% | -14.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Natural Alternatives International Inc dividends
Natural Alternatives International Inc has not paid dividends in the last 10 fiscal years.
Who owns Natural Alternatives International Inc
- Insiders 21.42%
- Institutions 36.10%
- Public & others 42.48%
- Shares outstanding 6.26M
- Free float 4.73M
Natural Alternatives International Inc company profile
- Company name
- Natural Alternatives International Inc
- Ticker
- NA2.F
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 301
- Fiscal year end
- June
- Address
- 1535 Faraday Avenue, Carlsbad, CA, United States, 92008
- Phone
- 760 736 7700
- Website
- nai-online.com
About Natural Alternatives International Inc
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. The company operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, and regulatory review. In addition, the company sells beta-alanine ingredients under the CarnoSyn, TriBsynm, CarnoSyn 4X, and SR CarnoSyn names. It manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. The company's private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Natural Alternatives International Inc management
3- Mr. Mark A. LeDoux J.D.Chairman of the Board & CEO · born 1954
- Mr. Kenneth E. Wolf CPAPresident, COO, Secretary, Principal Financial & Principal Accounting Officer · born 1961
- Mr. Shane ContiVice President of Global Sales